Search - tctmd.com

Displaying 221 - 240 of 849

Sort: Relevancy | Date

Presentation TCT 2017

Watchman: Step-by-step Recorded Case

Presenter: Ramon Quesada, Robert J. Sommer, Matthew J. Price

October 31, 2017

Presentation TCT 2017

Emerging TMVR 1: Cephea - Device Description, Critical Appraisal, and Development Plans

Presenter: Juan F. Granada

October 31, 2017

Presentation TCT 2017

Established TMVR 6: Caisson - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Presenter: Howard C. Herrmann, Michael J. Mack, Mathew Williams

October 31, 2017

Presentation TCT 2017

ACURATE Neo TAVR Technology Review and Clinical Program Updates

Presenter: Thomas Walther

October 31, 2017

Presentation TCT 2017

Sex and Racial Disparities in TAVR

Presenter: Alice K. Jacobs, Spencer B. King III, David R. Holmes Jr.

October 31, 2017

Presentation TCT 2017

Established TMVR 5: Highlife - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Presenter: Howard C. Herrmann, Michael J. Mack, Nicolo Piazza

October 31, 2017

Presentation TCT 2017

LOTUS Procedural Pearls (Including How NOT to Need a New Pacemaker)

Presenter: Nicolas M. Van Mieghem

October 31, 2017

Presentation TCT 2017

Established TMVR 4: Intrepid - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Presenter: Howard C. Herrmann, Michael J. Mack, Vinayak Bapat

October 31, 2017

Presentation TCT 2017

FDA Perspectives on TAVR Label Expansion Using Real-World Evidence, Valve Degeneration, and Embolic Protection Devices

Presenter: Martin B. Leon, Changfu Wu, John C Laschinger

October 31, 2017

Presentation TCT 2017

LOTUS TAVR Technology Review (Including EDGE) and Clinical Program Updates

Presenter: Michael J. Reardon

October 31, 2017

Presentation TCT 2017

Transpericardial Access for LAA Closure

Presenter: Stefan C. Bertog, Apostolos Tzikas, Krzysztof Bartus

October 31, 2017

Presentation TCT 2017

Established TMVR 3: Tendyne - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Presenter: Howard C. Herrmann, Michael J. Mack, David W.M. Muller

October 31, 2017

Presentation TCT 2017

EVOLUT R Procedural Pearls (Including how NOT to Need a New Pacemaker)

Presenter: Hemal Gada

October 31, 2017

Presentation TCT 2017

Valve Degeneration and Leaflet Mobility Considerations: Assessing Clinical Relevance

Presenter: Martin B. Leon, Changfu Wu, Lars Sondergaard

October 31, 2017

Presentation TCT 2017

Trans-septal Puncture for LAA Closure Using TEE Guidance

Presenter: Stefan C. Bertog, Apostolos Tzikas, Jacqueline Saw

October 31, 2017

Presentation TCT 2017

Established TMVR 2: Tiara - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Presenter: Howard C. Herrmann, Michael J. Mack, Anson Cheung

October 31, 2017

Presentation TCT 2017

EVOLUT R TAVR Technology Review (Including EVOLUT 34mm and PRO) and Clinical Program Updates

Presenter: John K. Forrest

October 31, 2017

Presentation TCT 2017

Embolic Protection Devices For TAVR Procedures: Lessons Learned From SENTINEL and Other Experiences

Presenter: Martin B. Leon, Changfu Wu

October 31, 2017

Presentation TCT 2017

Established TMVR 1: Cardiaq - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Presenter: Howard C. Herrmann, Michael J. Mack, James B. Hermiller Jr.

October 31, 2017

Presentation TCT 2017

Trans-septal Puncture for LAA Closure Using Fluoroscopic Guidance

Presenter: Stefan C. Bertog, Apostolos Tzikas, Randall J. Lee

October 31, 2017

Advertisement

Watchman: Step-by-step Recorded Case

Emerging TMVR 1: Cephea - Device Description, Critical Appraisal, and Development Plans

Established TMVR 6: Caisson - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

ACURATE Neo TAVR Technology Review and Clinical Program Updates

Sex and Racial Disparities in TAVR

Established TMVR 5: Highlife - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

LOTUS Procedural Pearls (Including How NOT to Need a New Pacemaker)

Established TMVR 4: Intrepid - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

FDA Perspectives on TAVR Label Expansion Using Real-World Evidence, Valve Degeneration, and Embolic Protection Devices

LOTUS TAVR Technology Review (Including EDGE) and Clinical Program Updates

Transpericardial Access for LAA Closure

Established TMVR 3: Tendyne - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

EVOLUT R Procedural Pearls (Including how NOT to Need a New Pacemaker)

Valve Degeneration and Leaflet Mobility Considerations: Assessing Clinical Relevance

Trans-septal Puncture for LAA Closure Using TEE Guidance

Established TMVR 2: Tiara - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

EVOLUT R TAVR Technology Review (Including EVOLUT 34mm and PRO) and Clinical Program Updates

Embolic Protection Devices For TAVR Procedures: Lessons Learned From SENTINEL and Other Experiences

Established TMVR 1: Cardiaq - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Trans-septal Puncture for LAA Closure Using Fluoroscopic Guidance

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content